We recently published a list of Top 10 Trending Stocks as AI Hype Fades. In this article, we are going to take a look at ...

Charles Schwab Investment Management Inc. lifted its position in shares of Protagonist Therapeutics, Inc. (NASDAQ:PTGX – Free ...

Some of the best psychological thrillers, action satires, and horror movies feature great unhinged protagonists.

Fast Company's annual list of the World's Most Innovative Companies spotlights organizations across various industries that are driving meaningful change through groundbreaking ideas and ...

Protagonist Therapeutics shares were up 28% to $49.25 after the company reported positive topline results from a Phase 2b study of icotrokinra, conducted by partner Johnson & Johnson.

GlobalData predicts that icotrokinra will reach blockbuster status in 2029, with the drug forecast to generate sales of ...

Protagonist Therapeutics (NASDAQ:PTGX – Get Free Report) had its target price boosted by equities researchers at BMO Capital ...

The protagonist of the new franchise of Naughty Dog will have an element of difference with respect to other games of the ...

As the Editor of Push Square, Sammy has over 15 years of experience analysing the world of PlayStation, from PS3 through PS5 ...

Grand Theft Auto VI is more than just another sequel in Rockstar’s legendary franchise—it’s a moment of change in the gaming ...